Skip to main content
. 2026 May 11;4:39. doi: 10.1038/s44259-026-00215-6

Table 2.

Molecular docking predicts that ADEP4, Sclerotiamide, and Birabresib selectively bind to specific amino acid residues (Supplementary Fig. S1) at the interface of two adjacent ClpP subunits from Bacillus subtills

ClpP residues ADEP4 Sclerotiamide Birabresib Birabresib matching
Ala107 0 1 0 1
Ala45 1 0 1 2
Arg15 1 1 0 2
Arg22 1 1 1 3
Asp18 1 1 1 3
ASP71 1 0 0 1
Gln46 1 0 1 2
Gln81 0 1 0 1
Glu14 0 1 0 1
Glu53 0 1 0 1
His156 1 1 0 2
Ile19 1 1 1 3
Ile29 0 0 1 1
Ile83 1 1 0 2
Leu24 1 1 1 3
Leu42 0 0 1 1
Lys108 0 1 0 1
Lys25 1 1 1 3
Lys84 0 1 0 1
Met98 1 0 0 1
Phe17 1 1 1 3
Phe30 1 0 1 2
Phe49 1 1 1 3
Phe82 0 1 0 1
Pro56 1 0 0 1
Ser16 1 1 0 2
Ser21 0 0 1 1
Ser21 1 0 1 2
Ser22 0 1 0 1
Ser45 1 0 0 1
Tyr20 1 0 1 2
Val03 0 0 1 1
Val5 1 0 0 1
Sum 21 19 16

Shaded numbers 2 or 3 indicates when Birabresib binds to the same ClpP amino acid residues as ADEP4 and/or Sclerotiamide.